Skip to main content
SpringerLink
Log in

Evaluating IV Drug Delivery Systems

Kappeler KH, Birdwell SW, Scheckelhoff DJ, Reilly CH. Model for evaluating costs associated with I.V. drug delivery systems. American Journal of Hospital Pharmacy 49; 1478–1481, 1992

  • Current Comment
  • Published:
PharmacoEconomics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Kappeler KH, Birdwell SW, Scheckelhoff DJ, Reilly CH. Model for evaluating costs associated with I.V. drug delivery systems. American Journal of Hospital Pharmacy 49: 1478–1481, 1992

    PubMed  CAS  Google Scholar 

  • Briceland LL, Outman WR, Nightingale CH, Quintiliani R. Cost considerations of conversion from aminoglycoside-containing combination regimens to ceftriaxone. Correspondence. Drug Intelligence and Clinical Pharmacy, Annals of Pharmacotherapy 25: 319–320, 1991

    CAS  Google Scholar 

  • DeTorres OH, White RE. Effect of aminoglycoside-use restrictions on drug cost. American Journal of Hospital Pharmacy 41: 1137–1139, 1984

    PubMed  CAS  Google Scholar 

  • Edson RS, Terrell. The aminoglycosides. Mayo Clinic Proceedings 66: 1158–1164, 1991

    PubMed  CAS  Google Scholar 

  • Eisenberg JM, Koffer H, Glick HA, Council ML, Loss LE. What is the cost of nephrotoxicity associated with aminoglycosides? Annals of Internal Medicine 107: 900–909, 1987

    PubMed  CAS  Google Scholar 

  • Flint LM, Gott J, Short L, Richardson JD, Polk HC. Serum level monitoring of aminoglycoside antibiotics. Limitations in intensive care unit-related bacterial pneumonia. Archives of Surgery 120: 99–103, 1985

    Article  PubMed  CAS  Google Scholar 

  • Holloway JJ, Smith CR, Moore RD, Ferroli ER, Lietman PS. Comparative cost effectiveness of gentamicin and tobramycin. Annals of Internal Medicine 101: 764–769, 1984

    PubMed  CAS  Google Scholar 

  • Matzke GR, Lucaroth PL, Shapiro HS. Controlled comparison of gentamicin and tobramycin nephrotoxicity. American Journal of Nephrology 3: 11–18, 1983

    Article  PubMed  CAS  Google Scholar 

  • McCormack JP, Jewesson PJ. A critical reevaluation of the Therapeutic Range of aminoglycosides. Clinical and Infectious Diseases 14: 320–329, 1992

    Article  CAS  Google Scholar 

  • Murray MD, Kohler RB, McCarthy MC, Main JW. Attitudes of house physicians concerning various antibiotic-use control programs. Am Journal of Hospital Pharmacy 45: 585–588, 1988

    Google Scholar 

  • Schentag JJ, Plaut ME, Cerra FB. Comparative nephrotoxicity of gentamicin and tobramycin: pharmacokinetic and clinical studies in 201 patients. Antimicrobial Agents Chemotherapy 19: 859–866, 1981

    Article  CAS  Google Scholar 

  • Schwinghammer TL, Romano MJ, Wing EJ. Cost savings associated with the use of gentamicin versus tobramycin. American Journal of Hospital Pharmacy 42: 1745–1749, 1985

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pharmacy (Clinical), St Francis Regional Medical Center, 929 N. St Francis, Wichita, KA 67214-3882, USA

    Jim Garrelts (Assistant Director)

Authors
  1. Jim Garrelts
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Garrelts, J. Evaluating IV Drug Delivery Systems. Pharmacoeconomics 3, 250–253 (1993). https://doi.org/10.2165/00019053-199303030-00008

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00019053-199303030-00008

Keywords

Search

Navigation